Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
General & GI surgery · Ruijin Hospital · Shanghai

Dr. Wu Zhichong吴志翀

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Wu Zhichong

Professional overview

Associate Chief Physician in the Department of General Surgery at Ruijin Hospital, specializing in diagnosis and treatment of benign and malignant tumors of the liver, biliary tract, and pancreas, with emphasis on laparoscopic and da Vinci robotic-assisted minimally invasive surgery.

SpecialtyGeneral & GI surgery
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentDepartment of General Surgery
HospitalRuijin Hospital
CityShanghai

Areas of focus

Laparoscopic surgerySpecializes in laparoscopic minimally invasive surgery for liver, biliary, and pancreatic diseases.
Robotic surgerySpecializes in da Vinci robotic-assisted minimally invasive surgery for liver, biliary, and pancreatic diseases.

Background

  • 2015Received Best Paper Award at the Joint Congress of the 8th Chinese Medical Doctor Association (CMDA) Surgical Division and the 19th European Society of Surgery.
  • 2015Received Outstanding Teaching Instructor Award from Ruijin Clinical Medical College.
  • 2016Received Outstanding Communist Youth League Member Award from Shanghai Jiao Tong University (2015–2016).
  • 2019Received Best Poster Award at the 13th World Congress on Immune Regulation (Davos, Switzerland).
  • 2021Awarded French Government Talent Passport for Researchers (Passeport Talent-Chercheur) by the French Ministry of Public Action and Accounts.
  • 2022Received Third Prize for Poster Presentation at the 4th International Conference on Stem Cells, Development and Cancer (Lyon, France).
  • 2023Principal Investigator of the Shanghai Magnolia Talent Program Pujiang Project (Grant No. 23PJ1408300), titled 'Exploratory Study on Targeting Pancreatic Cancer Stroma to Reverse Immunosuppressive Microenvironment and Improve Comprehensive Treatment Efficacy', funded by the Shanghai Science and Technology Commission (October 2023–September 2025).

Experience & recognition

  • Over 1,000 da Vinci robotic surgical procedures performed
  • Member of the American Pancreatic Association (APA), International Association of Pancreatology (IAP), French Pancreatic Tumor Association (AFRCP), European Association for Cancer Research (EACR), and French Society of Immunology (SFI)
  • Reviewer for journals including Cancer Letters and Medical Science Monitor

Professional roles

  • Youth Committee Member, Robotic Surgery Committee, Surgical Division, Chinese Medical Doctor Association (CMDA)
  • Member, Hepatobiliary and Pancreatic Branch, Academic Guidance Committee, Rehabilitation Society, China Anti-Cancer Association (CACA)
  • Member, Pancreatic Cancer Professional Committee, China Anti-Cancer Association (CACA)
  • Member, Shanghai Medical Doctor Association Surgical Division
  • Member, Chinese Association for Pancreatic Diseases (CAP)

Frequently asked questions

What does Dr. Wu Zhichong specialize in?

Specializes in diagnosis and treatment of benign and malignant tumors of the liver, biliary tract, and pancreas, especially using laparoscopic and da Vinci robotic-assisted minimally invasive surgery.

Which hospital and department is Dr. Wu Zhichong in?

Department of General Surgery at Ruijin Hospital

Sources

Dr. Wu Zhichong has not reviewed this page.